Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · IEX Real-Time Price · USD

15.16

+0.03 (0.20%)

At close: Jul 19, 2024, 4:00 PM

15.23

+0.07 (0.46%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Gyre Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2003
Net Income	-85.66	-92.93	2.3	-87.93	-56.24	-55.18	Upgrade
Depreciation & Amortization	1.95	1.43	1.49	0.29	0.14	0.15	Upgrade
Share-Based Compensation	7.08	7.28	13.37	3.41	3.63	3.2	Upgrade
Other Operating Activities	111.62	110.12	-6.48	0.48	-2.57	8.22	Upgrade
Operating Cash Flow	34.99	25.89	10.68	-83.76	-55.05	-43.61	Upgrade
Operating Cash Flow Growth	5.58%	142.50%	-	-	-	-	Upgrade
Capital Expenditures	-8.03	-7.85	-4.99	-0.84	-0.27	-0.06	Upgrade
Acquisitions	4.49	4.9	0	0	0	0	Upgrade
Change in Investments	-23.77	-16.74	-8.82	49.03	9.93	27.46	Upgrade
Other Investing Activities	-0.07	-0.07	-0.01	-	-	-	Upgrade
Investing Cash Flow	-27.39	-19.76	-13.81	48.19	9.66	27.39	Upgrade
Dividends Paid	7.76	0	0	0	0	0	Upgrade
Share Issuance / Repurchase	0.66	0	0	49.55	60.38	0.33	Upgrade
Other Financing Activities	2.5	2.5	-	-	-	-	Upgrade
Financing Cash Flow	10.92	2.5	0	49.55	60.38	0.33	Upgrade
Exchange Rate Effect	-0.34	-0.3	-1.89	0	0	0	Upgrade
Net Cash Flow	18.18	8.33	-5.03	13.99	14.99	-15.89	Upgrade
Free Cash Flow	26.96	18.04	5.69	-84.59	-55.32	-43.68	Upgrade
Free Cash Flow Growth	2.05%	216.92%	-	-	-	-	Upgrade
Free Cash Flow Margin	19.17%	15.90%	5.56%	-1152.82%	-264.06%	-	Upgrade
Free Cash Flow Per Share	0.32	0.27	0.09	-41.41	-43.26	-54.58	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).